Research News 4
Research News
-
amfAR Grantee Dr. Drew Weissman Awarded Nobel Prize
2023 Nobel Prize in Medicine awarded to Drs. Drew Weissman and Katalin Karikó for pioneering mRNA research leading to COVID-19 vaccines.
-
Combining CAR T Cell Strategies to Achieve an HIV Cure
amfAR researchers re-engage with anti-HIV CAR T cell therapies by exploring new ways to enhance their activity.
-
How Does the HIV Reservoir Avoid Destruction?
Researchers define new ways that latent HIV, the main barrier to a cure, evades destruction by the immune system’s natural killer cells.
-
New Case of Possible HIV Cure Reported
A new study that draws on the work of amfAR’s ICISTEM researchers reports a sixth person has potentially been cured of HIV via a stem cell transplant.
-
amfAR Grants Advance Gene Therapy Approaches to Curing HIV
In its latest round of grants, amfAR awards $2.4 million to researchers investigating gene therapy approaches to curing HIV.
-
Global Reach
amfAR’s wide-ranging research to be featured at International AIDS Conference on HIV Science 2023
-
The Promise of Gene Therapy
amfAR’s support of HIV cure research based on gene therapy approaches is vital—breakthroughs are needed no matter the cost.
-
Mapping a Moving Target
With a new mathematical modeling tool that more accurately predicts HIV mutations, researchers can potentially create more targeted interventions.
-
In Transplant-Driven Cures, What’s in Play Beyond the CCR5 Mutation?
In HIV cures driven by stem cell transplantation, an animal study helps define the importance of immunity in eradicating the viral reservoir.
-
On the Leading Edge of Cure Research
Leading researcher Prof. Sharon Lewin discusses her study refining the “shock and kill” approach to eradicate HIV and the future of HIV cure research.
-
Researchers Can Now Better Predict COVID-19 Severity
New discovery may better predict COVID-19 severity and help those living with SARS-CoV-2 who often fare the worst, including people with untreated HIV.
-
Solving the Puzzle of Post-Treatment Control
New study reveals clues about post-treatment controllers—people who are able to control HIV after antiretrovirals are stopped.
-
New Mathilde Krim Fellowship Awarded
amfAR awards Krim Fellowship to researcher Dr. Steven de Taeye for a study that will harness the ability of antibodies to help cure HIV.
-
Laying the Foundation for AIDS Research
40 years ago, Dr. Mathilde Krim co-founded AIDS Medical Foundation, the predecessor of amfAR, in order to propel AIDS research forward.
-
amfAR Cure Trial Shows Proof of Concept
Combination immunotherapy may induce virologic control after antiretroviral therapy is stopped, according to a new study that sheds light on curing HIV.